Alfons Meindl

Summary

Affiliation: Klinikum rechts der Isar
Country: Germany

Publications

  1. pmc Hereditary breast and ovarian cancer: new genes, new treatments, new concepts
    Alfons Meindl
    Klinikum rechts der Isar, aBteilung Gyn Tumorgenetik, Munchen
    Dtsch Arztebl Int 108:323-30. 2011
  2. pmc Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
    Ryan J Hartmaier
    Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    BMC Cancer 9:438. 2009

Collaborators

  • Karin Kast
  • Nina Ditsch
  • Ryan J Hartmaier
  • Norbert Arnold
  • Rita K Schmutzler
  • Sandrine Tchatchou
  • Jimmy M Rae
  • Bernhard H F Weber
  • Todd C Skaar
  • Kari Hemminki
  • Sean E McGuire
  • Peter Bugert
  • Barbara Wappenschmidt
  • Jay Wang
  • Christian Sutter
  • Alexandra S Richter
  • Claus R Bartram
  • Barbara Burwinkel
  • Raymonda Varon-Mateeva
  • Dieter Niederacher
  • Steffi Oesterreich

Detail Information

Publications2

  1. pmc Hereditary breast and ovarian cancer: new genes, new treatments, new concepts
    Alfons Meindl
    Klinikum rechts der Isar, aBteilung Gyn Tumorgenetik, Munchen
    Dtsch Arztebl Int 108:323-30. 2011
    ..Every year, 60,000 women in Germany are found to have breast cancer, and 9000 to have ovarian cancer. Familial clustering of carcinoma is seen in about 20% of cases...
  2. pmc Nuclear receptor coregulator SNP discovery and impact on breast cancer risk
    Ryan J Hartmaier
    Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    BMC Cancer 9:438. 2009
    ..Thus, we set out to identify novel single nucleotide polymorphisms (SNPs) within SRC-1 (NCoA1), SRC-3 (NCoA3, AIB1), NCoR (NCoR1), and SMRT (NCoR2), and test the most promising SNPs for associations with breast cancer risk...